Found: 16
Select item for more details and to access through your institution.
Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 35, p. 5, doi. 10.2807/1560-7917.ES.2022.27.35.2200636
- By:
- Publication type:
- Article
Application of Ambr15 system for simulation of entire SARS‐CoV‐2 vaccine production process involving macrocarriers.
- Published in:
- Biotechnology Progress, 2022, v. 38, n. 5, p. 1, doi. 10.1002/btpr.3277
- By:
- Publication type:
- Article
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.
- Published in:
- Archives of Toxicology, 2022, v. 96, n. 8, p. 2329, doi. 10.1007/s00204-022-03302-5
- By:
- Publication type:
- Article
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 491, doi. 10.3390/vaccines12050491
- By:
- Publication type:
- Article
Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 374, doi. 10.3390/vaccines12040374
- By:
- Publication type:
- Article
Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel ® 85 Protects K18-hACE2 Mice against Lethal Virus Challenge.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2119, doi. 10.3390/vaccines10122119
- By:
- Publication type:
- Article
Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains.
- Published in:
- Vaccines, 2019, v. 7, n. 1, p. 19, doi. 10.3390/vaccines7010019
- By:
- Publication type:
- Article
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26113-1
- By:
- Publication type:
- Article
Optimization of VSV‐ΔG‐spike production process with the Ambr15 system for a SARS‐COV‐2 vaccine.
- Published in:
- Biotechnology & Bioengineering, 2022, v. 119, n. 7, p. 1839, doi. 10.1002/bit.28088
- By:
- Publication type:
- Article
Development and Validation of an Innovative Analytical Approach for the Quantitation of Tris(Hydroxymethyl)Aminomethane (TRIS) in Pharmaceutical Formulations by Liquid Chromatography Tandem Mass Spectrometry.
- Published in:
- Molecules, 2023, v. 28, n. 1, p. 73, doi. 10.3390/molecules28010073
- By:
- Publication type:
- Article
Enhanced production yields of rVSV-SARS-CoV-2 vaccine using Fibra-Cel® macrocarriers.
- Published in:
- Frontiers in Bioengineering & Biotechnology, 2024, p. 01, doi. 10.3389/fbioe.2024.1333548
- By:
- Publication type:
- Article
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
- Published in:
- Molecules, 2021, v. 26, n. 11, p. 3213, doi. 10.3390/molecules26113213
- By:
- Publication type:
- Article
Virus Inactivation in Water Using Laser-Induced Graphene Filters.
- Published in:
- Materials (1996-1944), 2021, v. 14, n. 12, p. 3179, doi. 10.3390/ma14123179
- By:
- Publication type:
- Article
In-Line Monitoring of Downstream Purification Processes for VSV Based SARS-CoV-2 Vaccine Using a Novel Technique.
- Published in:
- BioTech, 2021, v. 10, n. 4, p. 1, doi. 10.3390/biotech10040025
- By:
- Publication type:
- Article
Highly Efficient Purification of Recombinant VSV-AG-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography.
- Published in:
- BioTech, 2021, v. 10, n. 4, p. 1, doi. 10.3390/biotech10040022
- By:
- Publication type:
- Article
A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-20228-7
- By:
- Publication type:
- Article